Position in AVXL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$518
-$96 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#170
of 180 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AVXL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Coston, McIsaac & Partners holds $16,716 across 4 Biotechnology names. AVXL ranks #3 (3.1% of the industry book) .
All Filings in AVXL
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $518 | 200 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $614 | 200 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $712 | 200 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1 | 200 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1 | 200 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1 | 200 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,148 | 200 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $1 | 200 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $844 | 200 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,018 | 200 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $1 | 200 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $1 | 200 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||